CHU de Caen, Service de Psychiatrie, Centre Esquirol, Caen, France.
Normandie Univ, UNICAEN, Imagerie et Strategies Therapeutiques de la schizophrenie (ISTS), EA4766, Caen, France.
Schizophr Bull. 2018 Apr 6;44(3):505-514. doi: 10.1093/schbul/sbx127.
Despite extensive testing, the efficacy of low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) of temporo-parietal targets for the treatment of auditory verbal hallucinations (AVH) in patients with schizophrenia is still controversial, but promising results have been reported with both high-frequency and neuronavigated rTMS. Here, we report a double-blind sham-controlled study to assess the efficacy of high-frequency (20 Hz) rTMS applied over a precise anatomical site in the left temporal region using neuronavigation.
Fifty-nine of 74 randomized patients with schizophrenia or schizoaffective disorders (DSM-IV R) were treated with rTMS or sham treatment and fully evaluated over 4 weeks. The rTMS target was determined by morphological MRI at the crossing between the projection of the ascending branch of the left lateral sulcus and the superior temporal sulcus (STS).
The primary outcome was response to treatment, defined as a 30% decrease of the Auditory Hallucinations Rating Scale (AHRS) frequency item, observed at 2 successive evaluations. While there was no difference in primary outcome between the treatment groups, the percentages of patients showing a decrease of more than 30% of AHRS score (secondary outcome) did differ between the active (34.6%) and sham groups (9.1%) (P = .016) at day 14.
This controlled study reports negative results on the primary outcome but demonstrates a transient effect of 20 Hz rTMS guided by neuronavigation and targeted on an accurate anatomical site for the treatment of AVHs in schizophrenia patients.
尽管进行了广泛的测试,但低频(1 Hz)重复经颅磁刺激(rTMS)治疗精神分裂症患者听觉言语幻觉(AVH)的疗效仍存在争议,但高频和神经导航 rTMS 已报告了有希望的结果。在这里,我们报告了一项双盲假对照研究,以评估使用神经导航在左颞区精确解剖部位应用高频(20 Hz)rTMS 的疗效。
74 名随机分配的精神分裂症或分裂情感障碍患者(DSM-IV R)中有 59 名接受了 rTMS 或假治疗,并在 4 周内进行了全面评估。rTMS 靶点由左外侧裂升支与上颞回(STS)投影交点的形态 MRI 确定。
主要结局是治疗反应,定义为在连续 2 次评估中听觉幻觉评定量表(AHRS)频率项下降 30%。虽然治疗组之间在主要结局上没有差异,但在活跃组(34.6%)和假治疗组(9.1%)中,AHRS 评分下降超过 30%的患者百分比(次要结局)在第 14 天有所不同(P =.016)。
这项对照研究报告了主要结局的阴性结果,但证明了经神经导航引导并针对精神分裂症患者 AVH 的准确解剖部位的 20 Hz rTMS 的短暂治疗效果。